Larisa J Geskin, MD, FAAD
SESSIONS
U021 Immunomodulatory Therapies and Cutaneous Lymphoma: Associations, Risks, and Clinical Implications
Mar 27, 2026
•
3:30 PM - 4:30 PM
•
Mile High 3A
DISCLOSURES
Actelion – Speaker/Faculty Education(Honoraria); Mallinckrodt Pharmaceuticals – Consultant(Honoraria);